Novavax, COVID
Is the Novavax COVID-19 Vaccine Better?
While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type of shot that uses a more traditional vaccine-making technology, used by Novavax.
On the hunt for Novavax: Why people are seeking out the 'traditional' COVID vaccine
Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.
Novavax or Nothing? For Some, It’s Their COVID Vaccine Choice
For many, Novavax is #1 – the one and only COVID vaccine they would consider. This enthusiasm for Novavax isn’t new. As far back as 2022, news reports described a kind of Novavax fan club – a term that irritates some – and it’s still here.
Why Novavax is Gaining Ground in COVID-19 Vaccine Race
Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the stock offers the best reward prospects in the industry.
Updated Novavax COVID-19 Vaccine Authorized for Use in Upcoming Season
The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.
FDA approves updated Novavax COVID vaccine amid summer surge
The Food and Drug Administration (FDA) granted emergency use authorization for an updated version of the Novavax COVID-19 vaccine amid the summer surge of infections. The new version of the vaccine “more closely targets” variants circulating nationwide,
Health Canada approves Novavax's updated COVID-19 vaccine for fall
Health Canada said Thursday it has authorized Novavax's updated COVID-19 vaccine for those aged 12 years and up. The product, called Nuvaxovid, is a protein-based vaccine. Health Canada said the vaccine was updated to target the JN.
Bay Area health officials encourage residents to get updates COVID vaccines
Read more: <a href=" Shohei Ohtani becomes the first major league player to exceed 50 homers and 50 steals in a season What to Do With Old Cell Phones (Because You Can’t Throw Them Away) House members bypass Mike Johnson a second time to force Social Security vote What’s on TV tonight: James Herriot returns in All Creatures Great and Small Researchers Study Life After Death — And It Gets Weirder 12 States Trying To Ban Gas Powered Cars (Even Though Voters Want Them) I’ve been retired in Mexico for 6 years—it's a luxury that ‘presents a new,
Health Canada approves updated Novavax COVID-19 vaccine
Health Canada has authorized Novavax's updated COVID-19 vaccine that protects against currently circulating variants of the virus.
CNET on MSN6d
What to Know About Novavax, the 'Other' COVID Vaccine
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
The turnaround man
Novavax occupies five sites in Montgomery County totaling about 370,000 square feet. Its footprint includes its headquarters ...
Novavax Inc. stock outperforms competitors on strong trading day
Novavax Inc. closed $10.57 below its 52-week high ($23.86), which the company reached on June 6th.
bovnews3d
Analysts Predict a $8 Target for Novavax Inc (NVAX) Stock—What Could Drive It There?
On Monday, Novavax Inc (NVAX) stock saw a decline, ending the day at $12.8 which represents a decrease of $-0.11 or -0.85% from the prior close of $12.91. The stock opened at $13.01 and touched a low ...
Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...
Novavax Inc. stock underperforms Monday when compared to competitors
Novavax Inc. closed $11.06 below its 52-week high ($23.86), which the company achieved on June 6th.
Zacks.com on MSN2d
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
Former Harmony CEO John Jacobs reshaping D.C. biotech with multibillion-dollar Sanofi deal
John Jacobs left Plymouth Meeting's Harmony Biosciences in 2023 after overseeing its IPO. Now, he's got another biotech firm ...